AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

“…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …”

Heatmaps of the top 536 differentially expressed genes (DEG) by calcitriol in CaSki cells with fold changes ranging from 1.5 to −1.5. by Euclides Avila (41023)

Subjects:

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adju... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and... by Laia Bertran (3685147)

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Percent change in age-standardized and delay-adjusted incidence rates of gastric cancer from 2019 to 2020, by age, race and sex in the United States, using the November 2022 data s... by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of signet ring carcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastrointestinal stromal tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and... by Armin Aslani (13009188)

Subjects:

Genomic downregulation of TGF β1 production in monocytes obtained after RZV administration. Panel A. The heatmap shows 16 genes on the y axis whose accessibility significantly changed between Days 0 and 90 after vaccination (FDR p < 0.1) in 8 participants shown on the x axis.... by Michael J. Johnson (5818168)

“…The heatmap shows 16 genes on the y axis whose accessibility significantly changed between Days 0 and 90 after vaccination (FDR p < 0.1) in 8 participants shown on the x axis. …”

Grading of cataractous changes adapted from Agarwal et al. (2013) [32]. by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Histopathological changes in pre-treated group, treated group and normal diet group. by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Temporal changes of older adults’ health level in the Yangtze River Economic Belt. by Mengmeng Yang (475288)

Subjects:

Age-specific estimated annual percentage changes in DALYs and death rates for 21 regions from 1990 to 2021. by Zhenhua Zhuang (11192745)

Subjects:

National age-standardized rates of DALYs and ASDR of IHD attributable to HSBP and their estimated annual percentage changes in 2021. by Zhenhua Zhuang (11192745)

Subjects: